Skip to main content

Table 4 Lipid profiles of coronary artery disease cases and controls according to APOC3 3238 C/G polymorphisms

From: Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

  CAD P value Controls P value
CC CG GG CC CG GG
TG (mg/dL) 162.3 ± 86.5 197.6 ± 90.4 253.9 ± 104.7 <0.001 138.7 ± 75.8 170.5 ± 80.6 224.6 ± 95.7 <0.001
TC (mg/dL) 199.4 ± 58.5 215.4 ± 62.7 196.3 ± 58.4 0.65 182.3 ± 47.1 213.8 ± 49.8 194.4 ± 48.7 0.74
HDL-C (mg/dL) 37.5 ± 11.1 40.8 ± 10.4 31.5 ± 9.8 0.56 37.4 ± 11.7 46.2 ± 14.5 41.7 ± 12.4 0.52
LDL-C (mg/dL) 127.1 ± 49.8 128.8 ± 49.8 105.7 ± 42.3 0.09 115.3 ± 34.9 130.6 ± 37.4 104.5 ± 32.7 0.34
VLDL-C (mg/dL) 34.8 ± 19.8 45.8 ± 24.1 59.1 ± 27.4 <0.001 29.6 ± 18.7 37.0 ± 20.1 48.2 ± 21.3 <0.001
ApoA1 (mg/dL) 124.6 ± 22.9 138.4 ± 25.6 125.2 ± 23.4 0.78 124.5 ± 22.1 135.6 ± 24.1 124.7 ± 21.8 0.68
ApoB (mg/dL) 88.3 ± 28.1 99.8 ± 30.1 89.1 ± 27.9 0.73 87.3 ± 24.2 97.7 ± 28.7 91.4 ± 25.7 0.82